| Autoimmune Bullous Skin Diseases | Lifetime | 20 | US 10 | 99.63 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 19 | US 9 | 99.50 |
| Systemic Lupus Erythematosus Research | Lifetime | 102 | US 41 | 99.54 |
| Urticaria and Related Conditions | Lifetime | 49 | US 19 | 99.32 |
| Skin Diseases and Diabetes | Lifetime | 19 | US 9 | 99.00 |
| Eosinophilic Disorders and Syndromes | Lifetime | 101 | US 57 | 99.01 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 483 | US 274 | 99.14 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 115 | US 48 | 98.70 |
| Dermatological and Skeletal Disorders | Lifetime | 62 | US 32 | 98.37 |
| T-cell and B-cell Immunology | Lifetime | 620 | US 324 | 98.86 |
| Systemic Sclerosis and Related Diseases | Lifetime | 235 | US 82 | 98.06 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 435 | US 195 | 97.68 |
| Dermatology and Skin Diseases | Lifetime | 703 | US 197 | 96.83 |
| Peripheral Neuropathies and Disorders | Lifetime | 631 | US 193 | 95.62 |
| Skin Protection and Aging | Lifetime | 615 | US 232 | 95.15 |
| Autoimmune and Inflammatory Disorders | Lifetime | 383 | US 121 | 94.64 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 781 | US 187 | 94.56 |
| Dupuytren's Contracture and Treatments | Lifetime | 141 | US 64 | 91.53 |
| Dermatologic Treatments and Research | Lifetime | 922 | US 374 | 92.53 |
| Skin and Cellular Biology Research | Lifetime | 744 | US 283 | 92.31 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 921 | US 360 | 92.56 |
| Celiac Disease Research and Management | Lifetime | 792 | US 176 | 91.76 |
| Drug-Induced Ocular Toxicity | Lifetime | 158 | US 85 | 90.57 |
| Dermatological and COVID-19 studies | Lifetime | 302 | US 78 | 87.68 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 264 | US 91 | 89.25 |
| Hair Growth and Disorders | Lifetime | 684 | US 247 | 89.03 |
| Medicine and Dermatology Studies History | Lifetime | 524 | US 202 | 86.79 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 11 | US 6 | 99.58 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 6 | US 5 | 99.46 |
| T-cell and B-cell Immunology | 2021-2025 | 25 | US 18 | 98.79 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 15 | US 6 | 99.19 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 53 | US 21 | 98.61 |
| Urticaria and Related Conditions | 2021-2025 | 32 | US 8 | 98.46 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 36 | US 25 | 98.30 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 32 | US 11 | 95.70 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 42 | US 15 | 97.41 |
| Dermatological and Skeletal Disorders | 2021-2025 | 20 | US 12 | 93.01 |
| Skin Diseases and Diabetes | 2021-2025 | 23 | US 11 | 90.50 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 653 | US 280 | 93.68 |
| Celiac Disease Research and Management | 2021-2025 | 97 | US 17 | 91.53 |
| Dermatology and Skin Diseases | 2021-2025 | 679 | US 159 | 90.29 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 494 | US 100 | 88.00 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 374 | US 80 | 86.61 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 768 | US 198 | 85.07 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 86 | US 24 | 80.13 |
| Drug-Induced Ocular Toxicity | 2021-2025 | 89 | US 29 | 63.45 |
| Dupuytren's Contracture and Treatments | 2021-2025 | 180 | US 54 | 50.77 |
| Medicine and Dermatology Studies History | 2021-2025 | 403 | US 198 | 39.50 |
